CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung ...

One computer scientist’s “stunning” proof is the first progress in 50 years on one of the most famous questions in computer ...